Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
486
Value
$1.01K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ALLO by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026486$1.01K<0.1%−86−15.0%ReducedHolders
Q1 2026572$1.40K<0.1%+572NewHolders
Q3 20250$00.0%−184−100.0%Sold outHolders
Q2 2025184$208<0.1%−6,784−97.4%ReducedHolders
Q1 20256,968$10.2K<0.1%+6,229+842.9%AddedHolders
Q4 2024739$1.57K<0.1%−1,043−58.5%ReducedHolders
Q3 20241,782$4.99K<0.1%+212+13.5%AddedHolders
Q2 20241,570$3.66K<0.1%−1,813−53.6%ReducedHolders
Q1 20243,383$15.1K<0.1%00.0%UnchangedHolders
Q4 20233,383$10.9K<0.1%+826+32.3%AddedHolders
Q3 20232,557$8.11K<0.1%+859+50.6%AddedHolders
Q2 20231,698$8.44K<0.1%+1,210+248.0%AddedHolders
Q1 2023488$2.41K<0.1%−2,842−85.3%ReducedHolders
Q4 20223,330$20.9K<0.1%−1,593−32.4%ReducedHolders
Q3 20224,923$54.0K<0.1%−551−10.1%ReducedHolders
Q2 20225,474$63.0K<0.1%+1,616+41.9%AddedHolders
Q1 20223,858$35.0K<0.1%+1,010+35.5%AddedHolders
Q4 20212,848$42.0K<0.1%+2,301+420.7%AddedHolders
Q3 2021547$14.0K<0.1%−9,863−94.7%ReducedHolders
Q2 202110,410$271.0K<0.1%+42+0.4%AddedHolders
Q1 202110,368$366.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.